Clinical Trial Update: The Use of Topical Oxybutynin 10% for Treating Primary Focal Hyperhidrosis-axillary, Palmar and Plantar. [NA]

View source ↗

Summary

This clinical trial update reports the completed study evaluating topical oxybutynin 10% for primary focal hyperhidrosis affecting the axillae, palms, and soles…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperhidrosis

Drugs mentioned

• Topical oxybutynin 10% (oxybutynin)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Hyperhidrosis | NA | Status: COMPLETED